Literature DB >> 1898915

Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated).

S J Devi1, R Schneerson, W Egan, W F Vann, J B Robbins, J Shiloach.   

Abstract

A surface polysaccharide antigen of Moraxella nonliquefaciens, reported to be cross-reactive with the capsular polysaccharides of group B Neisseria meningitidis and Escherichia coli K1 (K. Błvre, K. Bryn, O. Closs, N. Hagen, and L. O. Froholm, NIPH Ann. 6:65-73, 1983), was isolated, purified, and characterized chemically, immunologically, and by nuclear magnetic resonance. This polysaccharide was shown to be a linear homopolymer of alpha (2----8)-linked N-acetylneuraminic acid, identical to the capsular polysaccharide of group B N. meningitidis and O-acetyl-negative variants of E. coli K1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898915      PMCID: PMC257823          DOI: 10.1128/iai.59.2.732-736.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Multiple oligosaccharide chains in the voltage-sensitive Na channel from electrophorus electricus: evidence for alpha-2,8-linked polysialic acid.

Authors:  W M James; W S Agnew
Journal:  Biochem Biophys Res Commun       Date:  1987-10-29       Impact factor: 3.575

2.  The taxonomy of the genera Moraxella and Neisseria.

Authors:  S D Henriksen; K Bovre
Journal:  J Gen Microbiol       Date:  1968-05

3.  A Moraxella-like microorganism isolated from the genito-urinary tract of man.

Authors:  H Lautrop; K Bovre; W Frederiksen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

4.  Basic principles of Antigen-Antibody Reactions.

Authors:  E A Kabat
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

Authors:  J Finne; M Leinonen; P H Mäkelä
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

Review 6.  Capsular polysaccharides as human vaccines.

Authors:  H J Jennings
Journal:  Adv Carbohydr Chem Biochem       Date:  1983       Impact factor: 12.200

7.  The Escherichia coli K1 capsule shares antigenic determinants with the human gangliosides GM3 and GD3.

Authors:  T Söderström; G Hansson; G Larson
Journal:  N Engl J Med       Date:  1984-03-15       Impact factor: 91.245

8.  Infections caused by Moraxella, Moraxella urethralis, Moraxella-like groups M-5 and M-6, and Kingella kingae in the United States, 1953-1980.

Authors:  D R Graham; J D Band; C Thornsberry; D G Hollis; R E Weaver
Journal:  Rev Infect Dis       Date:  1990 May-Jun

9.  Determination of sialic acids by acidic ninhydrin reaction.

Authors:  K Yao; T Ubuka
Journal:  Acta Med Okayama       Date:  1987-12       Impact factor: 0.892

10.  A novel neutral oligosaccharide chain found in polysialoglycoproteins isolated from Pacific salmon eggs. Structural studies by secondary ion mass spectrometry, proton nuclear magnetic resonance spectroscopy, and chemical methods.

Authors:  M Shimamura; T Endo; Y Inoue; S Inoue
Journal:  Biochemistry       Date:  1983-02-15       Impact factor: 3.162

View more
  17 in total

1.  Mutant bacteriophage with non-catalytic endosialidase binds to both bacterial and eukaryotic polysialic acid and can be used as probe for its detection.

Authors:  J Aalto; S Pelkonen; H Kalimo; J Finne
Journal:  Glycoconj J       Date:  2001-10       Impact factor: 2.916

2.  Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.

Authors:  S J Devi; W D Zollinger; P J Snoy; J Y Tai; P Costantini; F Norelli; R Rappuoli; C E Frasch
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24.

Authors:  G P Reddy; U Hayat; C Abeygunawardana; C Fox; A C Wright; D R Maneval; C A Bush; J G Morris
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

4.  Functional and structural characterization of polysaccharide co-polymerase proteins required for polymer export in ATP-binding cassette transporter-dependent capsule biosynthesis pathways.

Authors:  Kane Larue; Robert C Ford; Lisa M Willis; Chris Whitfield
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

Review 5.  Diversity of microbial sialic acid metabolism.

Authors:  Eric R Vimr; Kathryn A Kalivoda; Eric L Deszo; Susan M Steenbergen
Journal:  Microbiol Mol Biol Rev       Date:  2004-03       Impact factor: 11.056

6.  Identification of amino acid residues at the active site of endosialidase that dissociate the polysialic acid binding and cleaving activities in Escherichia coli K1 bacteriophages.

Authors:  Elina Jakobsson; Anne Jokilammi; Juha Aalto; Pauli Ollikka; Jukka V Lehtonen; Harri Hirvonen; Jukka Finne
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

7.  Human immunoglobulin M paraproteins cross-reactive with Neisseria meningitidis group B polysaccharide and fetal brain.

Authors:  F H Azmi; A H Lucas; H L Spiegelberg; D M Granoff
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

Review 8.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

9.  A new sialidase mechanism: bacteriophage K1F endo-sialidase is an inverting glycosidase.

Authors:  Thomas J Morley; Lisa M Willis; Chris Whitfield; Warren W Wakarchuk; Stephen G Withers
Journal:  J Biol Chem       Date:  2009-05-01       Impact factor: 5.157

Review 10.  Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules.

Authors:  Brady F Cress; Jacob A Englaender; Wenqin He; Dennis Kasper; Robert J Linhardt; Mattheos A G Koffas
Journal:  FEMS Microbiol Rev       Date:  2014-01-27       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.